DES UPDATE For you, your family, and your health care provider DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION CDC Launches New, Comprehensive Information Resource

First Page		Document Content
Date: 2012-09-06 14:07:36 Eli Lilly and Company Phenols Teratogens Vaginal cancer Medicine Centers for Disease Control and Prevention Diethylstilbestrol		DES UPDATE For you, your family, and your health care provider DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION CDC Launches New, Comprehensive Information Resource Add to Reading List Source URL: www.cdc.gov Download Document from Source Website File Size: 58,25 KB Share Document on Facebook

	Behavioral and Somatic Disorders in Children exposed in utero to Synthetic Hormones: a Testimony-Case Study in a French Family Troop Marie-Odile Soyer-Gobillard1* Ph.D. and Charles Sultan2,3 MD, Ph.D. 1 Centre National DocID: 1g8iU - View Document
	Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study Prenatal diethylstilbestrol (DES)-exposed mice have raised the suspicion of a tran DocID: 1fOfv - View Document
	Mise au point ! Complications liées à l’exposition in utero au diéthylstilbestrol (DES) (Distilbène®, Stilboestrol-Borne®) DocID: 1bwp1 - View Document
	Research Estrogen Receptor-α Mediates Diethylstilbestrol-Induced Feminization of the Seminal Vesicle in Male Mice Vickie R. Walker,1 Wendy N. Jefferson,2 John F. Couse,1,3 and Kenneth S. Korach1 1Receptor Biology Sectio DocID: 1aKYk - View Document
	AMERICAN CHEMISTRY COUNCIL LONG-RANGE RESEARCH INITIATIVE REQUEST FOR PROPOSALS RfP Title: Investigation of the “Low-Dose” Hypothesis for Estrogenic or DocID: 1aeUD - View Document